Advertisement

Half of Hospitals Have Implemented No Price Transparency

0

Only 5.7 percent of hospitals meet both requirements -- a machine-readable file for required price types and an accessible display for at least 300 shoppable items

New Drug Launch Prices Increasing Exponentially Each Year

0

Findings among newly marketed brand-name prescription drugs launched in 2008 to 2021

Risk for SARS-CoV-2 Breakthrough Infections Up in Persons With HIV

0

Risk for breakthrough infections increased in association with younger age, history of COVID-19, not receiving additional vaccine dose

Actions Against Physician Licenses Due to Substance Use Down

0

However, despite declines from 2004 to 2020, substance use-related actions remain much higher than actions for physical, psychological impairment

Despite Improvements

Hispanic, Black Physicians Underrepresented in the United States

0

With sustained doubling of Hispanic and Black medical students, it would take 92 and 66 years to correct deficit of physicians

Medical technology concept. Doctor working with mobile phone and stethoscope in modern office

AMA Survey Shows Lack of Progress on Prior Authorization Reforms

0

Results show little progress across all five reform areas outlined in 2018 consensus statement

Es 1

Survey IDs Challenges of Health Care Environmental Hygiene

0

50 of 51 health care facilities surveyed lacking in some or all of the five components of the WHO multimodal hand hygiene strategy

Medical Errors and Doctor Burnout

Physicians Often Experience Mistreatment, Discrimination

0

Experience of mistreatment or discrimination by patients, families, visitors independently linked with higher odds of burnout

Increased Flexibility Seen in Preapproval Evidence for New Drugs

0

Twenty-eight percent of trials used historical, external, or other control; nearly half used surrogate measure as a primary end point

Lenacapavir Reduces Viral Load in Multidrug-Resistant HIV-1 Infection

0

Reduction in viral load from baseline greater with lenacapavir versus placebo among those with multidrug-resistant HIV-1 infection